Translational Bridge Symposium
Register now for the December 1 eventThe Robert H. Lurie Comprehensive Cancer Center of Northwestern University is committed to fostering collaborations between physicians, basic scientists, and population scientists with the ultimate goal of translating research discoveries to the clinic and community, thereby improving cancer patient outcomes. This symposium is designed to stimulate these collaborations and inform the NU community of opportunities to translate their work.
Event Details
Agenda
FEATURED SPEAKER:
Targeted Protein Degradation for Cancer Therapy
Gary Schiltz, PhD
Lurie Cancer Center
Covalent Inhibitors and PROTAC Degraders of the TEAD/YAP1 Transcriptional Complex
Samy Meroueh, PhD
Indiana University School of Medicine
Targeting MYC with Small Molecule Inhibitors
Sarki Abdulkadir, MD, PhD
Lurie Cancer Center
Pleckstrin-2: from Discovery to Drug Target
Peng Ji, MD, PhD
Lurie Cancer Center
Translational Bridge Trainee Talks
Conference Chairs
Daniela Matei, MD
Amy Heimberger, MD
Jodi Johnson, PhD
Northwestern University Feinberg School of Medicine
Additional Information
For additional information about the event, please contact cancer@northwestern.edu.